Mizuho raised the firm’s price target on Elevance Health (ELV) to $505 from $455 and keeps an Outperform rating on the shares. The firm ...

Guggenheim initiated coverage of Elevance Health (ELV) with a Buy rating and $518 price target The firm launched coverage on 11 healthcare ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

With its strong position in managed care and a stable revenue stream from government-backed programs, Elevance Health became a preferred choice for risk-averse investors. In addition to the sector ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

Elevance Health (NYSE:ELV) is one of America's largest health insurers, serving approximately 47 million medical members through its network-based managed care plans. Larger companies benefit from ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...

Equities researchers at Wolfe Research issued their FY2029 earnings per share (EPS) estimates for Elevance Health in a note issued to investors on Monday, March 31st. Wolfe Research analyst J. Lake ...

A Relative Strength Rating upgrade for Elevance Health shows improving technical performance. Will it continue?

Elevance Health remains a buy with its strong fundamentals ... ELV offers medical, pharmacy, behavioral, clinical, and complex care solutions. Its operations are organized around three core ...

Elevance Health Companies, which is affiliated with area insurance company Blue Cross and Blue Shield, filed the objection on ...